NCT05772936 is a NA clinical trial of Balance training in Stroke, Cerebrovascular, sponsored by Northwestern University.

Who is sponsoring NCT05772936?

NCT05772936 is sponsored by Northwestern University.

What drugs are being tested in NCT05772936?

Interventions in NCT05772936: Balance training.

What condition does NCT05772936 study?

NCT05772936 studies Stroke, Cerebrovascular.

Is NCT05772936 still recruiting?

NCT05772936 is currently completed. Last updated 17 March 2023.

Last reviewed 2023-03-17 · How we verify

NCT05772936

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Reactive Standing Balance Step Training Post Stroke

Completed NA Last updated 17 March 2023

What this trial tests

NA trial testing Balance training in Stroke, Cerebrovascular in 13 participants. Completed in 6 February 2023.

Timeline

22 January 2019

Primary endpoint
6 February 2023

6 February 2023

Quick facts

Lead sponsor	Northwestern University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	13
Start date	22 January 2019
Primary completion	6 February 2023
Estimated completion	6 February 2023
Sites	1 location across United States

Drugs / interventions tested

Balance training

Conditions studied

Stroke, Cerebrovascular — all drugs for Stroke, Cerebrovascular →

Sponsor

Northwestern University

Who can join

Adults 21 to 80, any sex, with Stroke, Cerebrovascular. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the effectiveness of reactive step training on the timing and frequency of perturbation induced paretic leg stepping in persons post stroke. The study will consist of one or six one-hour training sessions and a pre and post visit each lasting up to two hours at our downtown Chicago location.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Balance training

Trials testing the same drug.

NCT07333989 — Effect of Biofeedback Activation on Balance in Osteoporotic Elderly · NA · recruiting
NCT07350655 — Efficacy of Virtual Reality-based Training in Patients With Chronic Non-specific Low Back Pain · NA · active not recruiting
NCT07283276 — Effect of Functional Core Stability Training or Cognitive Training on Balance and Postural Control in Chronic Ankle Inst · NA · recruiting
NCT07390760 — Remote Ischemic Conditioning and Spinal Reflex Modulation in Children With Cerebral Palsy · NA · recruiting
NCT07000214 — Peripheral Magnetic Stimulation With Balance Training to Decrease Fall Risks in Diabetic Polyneuropathy · Phase 2 · recruiting

Other recruiting trials for Stroke, Cerebrovascular

Currently open trials in the same condition.

NCT06127602 — The REACTplusNMES Trial: A Double-blinded RCT · NA · recruiting
NCT05443633 — Enhancing Language Function in Aphasia · NA · recruiting

Other Northwestern University trials

Trials by the same sponsor.

NCT06545695 — Epidermal Growth Factor Receptor Inhibition for Keratinopathies · Phase 1, PHASE2 · not yet recruiting
NCT07261657 — N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive C · EARLY_PHASE1 · not yet recruiting
NCT07392775 — ALDH2 Genetic Testing in East Asian Community · NA · not yet recruiting
NCT06886776 — Implementing A Secure Firearm Storage Program in Illinois Health Centers in Partnership With AllianceChicago and the Ill · NA · not yet recruiting
NCT07469176 — Co-Designing and Evaluating Additional Mothers and Babies Program Content for Expectant and New Parents of Children With · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05772936 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Northwestern University
Last refreshed: 17 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05772936.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing